Clinical trial

Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

NCT04834557

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-11-01

PhasePHASE2

Study timeline

Study start (actual)2021-11-01Date precision: day

Registry last updated2023-03-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

PlaceboDRUG

Digoxin 0.25 mgDRUG · verified · RxNorm: digoxin 0.25 MG

Ursodeoxycholic acid (UDCA) 500 mgDRUG

Sponsors & collaborators

Tanta Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04834557 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.